azithromycin
PolandDrugs containing this active substance
-
The medicine is used for the treatment of, among others, acute inflammation of the sinuses, middle ear, throat and tonsils, exacerbations of chronic bronchitis, mild or moderate pneumonia, as well as skin and soft tissue infections, and uncomplicated infections caused by Chlamydia trachomatis.
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicinal product is intended for the treatment of infections caused by bacteria, such as: sinusitis, pharyngitis, tonsillitis, otitis media, bronchitis, pneumonia, as well as skin infections (e.g., erythema migrans in Lyme disease, erysipelas, impetigo) and sexually transmitted diseases (e.g., uncomplicated urethritis or cervicitis).
Form: tablets, film-coated
Active substance Dosage azithromycin 524 mg ATC: J01FA10
Manufacturer: Krka Polska Sp. z o.o.
-
The medicine is used to treat infections caused by susceptible microorganisms, such as: upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), and skin and soft tissue infections (e.g., erysipelas, impetigo, erythema migrans).
Form: tablets, film-coated
Active substance Dosage azithromycin 125 mg ATC: J01FA10
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicine is used to treat infections caused by susceptible microorganisms, such as: upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections, and certain sexually transmitted diseases.
Form: tablets, film-coated
Active substance Dosage azithromycin 250 mg ATC: J01FA10
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicine is used to treat infections caused by susceptible microorganisms, including upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections (e.g., erysipelas, impetigo, adult acne), and sexually transmitted diseases (e.g., Chlamydia trachomatis).
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicine is used to treat infections caused by susceptible microorganisms, such as: upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), and skin and soft tissue infections (e.g., erysipelas, impetigo, erythema migrans).
Form: powder for preparation of oral suspension
Active substance Dosage azithromycin 104.8 mg/5 ml ATC: J01FA10
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicinal product is used to treat infections caused by susceptible microorganisms, such as: upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), and skin and soft tissue infections (e.g., erysipelas, impetigo, erythema migrans).
Form: powder for preparation of oral suspension
Active substance Dosage azithromycin 209.6 mg/5 ml ATC: J01FA10
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicine is used for the topical treatment of various bacterial eye infections in adults and children (from birth to 17 years of age). It helps in cases of purulent conjunctivitis and trachomatous conjunctivitis.
Form: drops, ophthalmic solution in single-dose container
Active substance Dosage azithromycin 15 mg/g ATC: S01AA26
Manufacturer: Laboratoires THEA
-
The medicine is used to treat infections caused by bacteria, such as: chest infections (pneumonia, bronchitis), throat, nose, sinus, and tonsil infections, ear infections, skin and soft tissue infections (e.g., abscess, boil), and sexually transmitted diseases (Chlamydia trachomatis and Neisseria gonorrhoea).
Form: tablets, film-coated
Active substance Dosage azithromycin 262 mg ATC: J01FA10
Manufacturer: APL Swift Services (Malta) Ltd.
-
The medicine is used to treat bacterial infections, such as bronchitis, pneumonia, tonsillitis, sinusitis, pharyngitis, and rhinitis, as well as ear, skin, and soft tissue infections (e.g., abscess or boil) and sexually transmitted diseases (Chlamydia trachomatis and Neisseria gonorrhoea).
Form: tablets, film-coated
Active substance Dosage azithromycin 524 mg ATC: J01FA10
Manufacturer: APL Swift Services (Malta) Ltd.
-
This is an antibiotic used to treat bacterial infections, such as pneumonia, exacerbation of chronic bronchitis, sinusitis, pharyngitis, tonsillitis, otitis media, as well as skin and soft tissue infections, and uncomplicated urethral or cervical infections caused by Chlamydia trachomatis bacteria.
Form: tablets, film-coated
Active substance Dosage azithromycin 524.04 mg ATC: J01FA10
Manufacturer: PSI supply n.v. Synoptis Industrial Sp. z o.o.
-
The medicinal product is used for the treatment of, among others, acute bacterial sinusitis, otitis media, tonsillitis, pharyngitis, exacerbation of chronic bronchitis, pneumonia, and certain infections of the skin, soft tissues, and genital tract.
Form: tablets, film-coated
Active substance Dosage azithromycin 262.05 mg ATC: J01FA10
Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH
-
The medicine is used to treat, among other things, acute bacterial sinusitis, otitis media, tonsillitis, pharyngitis, exacerbation of chronic bronchitis, pneumonia, and certain skin, soft tissue, and urogenital tract infections (e.g., caused by Chlamydia trachomatis).
Form: tablets, film-coated
Active substance Dosage azithromycin 524.1 mg ATC: J01FA10
Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH
-
The medicinal product is an antibiotic used to treat bacterial infections, such as pneumonia, chronic bronchitis, tonsillitis, pharyngitis, sinusitis, otitis, as well as skin and soft tissue infections, and urethral and cervical infections caused by Chlamydia.
Form: powder for preparation of oral suspension
Active substance Dosage azithromycin 104.8 mg/5 ml ATC: J01FA10
Manufacturer: Lek Pharmaceuticals d.d. Novartis Pharmaceuticals S.R.L. Salutas Pharma GmbH
-
This medicine is an antibiotic used to treat bacterial infections, such as pneumonia, chronic bronchitis, tonsillitis, pharyngitis, sinusitis, otitis, as well as skin and soft tissue infections, and urethral and cervical infections caused by chlamydia.
Form: powder for preparation of oral suspension
Active substance Dosage azithromycin 209.6 mg/5 ml ATC: J01FA10
Manufacturer: Lek Pharmaceuticals d.d. Novartis Pharmaceuticals S.R.L. Salutas Pharma GmbH
-
This is an antibiotic used to treat infections caused by bacteria, such as upper and lower respiratory tract infections (e.g., sinuses, throat, tonsils, bronchitis, pneumonia), acute otitis media, skin and soft tissue infections, erythema migrans, and uncomplicated genital tract infections caused by Chlamydia trachomatis.
Form: suspension, oral, for preparation from tablets
Active substance Dosage azithromycin No input provided ATC: J01FA10
Manufacturer: PLIVA Hrvatska d.o.o. (Pliva Croatia Ltd.), Teva Operations Polska Sp. z o.o.
-
This is an antibiotic used to treat bacterial infections, such as pneumonia, chronic bronchitis, infections of the throat, tonsils, sinuses, ear, skin, and soft tissues, as well as infections of the urethra and cervix caused by chlamydia.
Form: tablets, film-coated
Active substance Dosage azithromycin 250 mg ATC: J01FA10
Manufacturer: 1 A Pharma GmbH
-
This is an antibiotic used to treat bacterial infections, such as pneumonia, chronic bronchitis, sinusitis, pharyngitis, tonsillitis, otitis, skin and soft tissue infections, as well as urethral and cervical infections caused by chlamydia.
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: 1 A Pharma GmbH
-
The medicine is used to treat upper respiratory tract infections (e.g., pharyngitis, tonsillitis, sinusitis), otitis media, lower respiratory tract infections (e.g., bronchitis, pneumonia), skin and soft tissue infections (e.g., erythema migrans, erysipelas, adult acne), and sexually transmitted diseases (e.g., chlamydiosis).
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: Zentiva, joint-stock company
-
It is used in the treatment of infections caused by susceptible microorganisms, such as: upper respiratory tract infections (e.g., pharyngitis, tonsillitis, sinusitis), acute otitis media, lower respiratory tract infections (e.g., bronchitis, pneumonia), and skin and soft tissue infections (e.g., erysipelas, impetigo, erythema migrans).
Form: powder for preparation of oral suspension
Active substance Dosage azithromycin 200 mg/ 5 ml ATC: J01FA10
Manufacturer: Adamed Pharma S.A. Teva Operations Polska Sp. z o.o.
-
The medicine is used to treat infections caused by bacteria, such as: upper respiratory tract infections (sore throat, tonsillitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections, and certain sexually transmitted diseases.
Form: tablets, film-coated
Active substance Dosage azithromycin 250 mg ATC: J01FA10
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to treat various bacterial infections, such as infections of the throat, tonsils, sinuses, middle ear, bronchi, and lungs, as well as skin infections (e.g., erysipelas, impetigo, acne in adults) and sexually transmitted diseases (e.g., Chlamydia trachomatis infections).
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to treat upper respiratory tract infections (e.g., pharyngitis, tonsillitis, sinusitis), acute otitis media, lower respiratory tract infections (e.g., bronchitis, pneumonia), skin and soft tissue infections (e.g., erysipelas, impetigo, erythema migrans), and uncomplicated sexually transmitted diseases (Chlamydia trachomatis infections).
Form: tablets, film-coated
Active substance Dosage azithromycin 524.109 mg ATC: J01FA10
Manufacturer: Pliva Croatia Ltd. (Pliva Croatia Ltd.) Teva Operations Poland Sp. z o.o.
-
The medicinal product is used to treat infections caused by susceptible microorganisms, including upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis), lower respiratory tract infections (bronchitis, pneumonia), otitis media, skin and soft tissue infections (e.g., erysipelas, impetigo, adult acne), and sexually transmitted diseases.
Form: tablets, film-coated
Active substance Dosage azithromycin 524.1 mg ATC: J01FA10
Manufacturer: ICN Polfa Rzeszów S.A.
-
The medicine is intended for the treatment of, among others, upper respiratory tract infections (sore throat, tonsillitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections (erysipelas, impetigo, common acne in adults), and certain sexually transmitted diseases.
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.
-
The medicinal product is used to treat infections caused by susceptible microorganisms, such as: upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), and skin and soft tissue infections (e.g., erysipelas, impetigo, erythema migrans).
Form: powder for preparation of oral suspension
Active substance Dosage azithromycin 25.047 mg/g ATC: J01FA10
Manufacturer: Pliva Croatia Ltd. (Pliva Croatia Ltd.) Teva Operations Poland Sp. z o.o.
-
The medicine is used to treat infections caused by bacteria, such as: upper respiratory tract infections (sinuses, throat, tonsils), acute otitis media, chest infections (bronchitis, pneumonia), skin and soft tissue infections, erythema migrans (the first symptom of Lyme disease), and uncomplicated genital tract infections caused by Chlamydia trachomatis.
Form: suspension, oral, for preparation from tablets
Active substance Dosage azithromycin 250 mg ATC: J01FA10
Manufacturer: PLIVA Hrvatska d.o.o. (Pliva Croatia Ltd.), Teva Operations Polska Sp. z o.o.
-
The medicinal product is used to treat infections caused by bacteria, such as upper and lower respiratory tract infections (e.g., sinuses, throat, tonsils, bronchi, lungs), acute otitis media, skin and soft tissue infections, erythema migrans (the first symptom of Lyme disease), and uncomplicated genital tract infections caused by Chlamydia trachomatis.
Form: suspension, oral, for preparation from tablets
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: PLIVA Hrvatska d.o.o. (Pliva Croatia Ltd.), Teva Operations Polska Sp. z o.o.
-
The medicinal product is used to treat infections caused by bacteria, such as upper and lower respiratory tract infections (e.g., sinuses, throat, tonsils, bronchi, lungs), acute otitis media, skin and soft tissue infections, erythema migrans (the first symptom of Lyme disease), and uncomplicated genital tract infections caused by Chlamydia trachomatis.
Form: suspension, oral, for preparation from tablets
Active substance Dosage azithromycin 1000 mg ATC: J01FA10
Manufacturer: PLIVA Hrvatska d.o.o. (Pliva Croatia Ltd.), Teva Operations Polska Sp. z o.o.
-
The medicine is intended for the treatment of, among others, upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections (erysipelas, impetigo, common acne in adults), and sexually transmitted diseases (Chlamydia trachomatis infections).
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: Teva Nederland B.V.
-
The medicine is intended for the treatment of various bacterial infections, such as: inflammation of the throat, tonsils, sinuses, middle ear, bronchi, and lungs. It is also used in skin and soft tissue infections (e.g., erysipelas, impetigo, erythema migrans, adult acne) and in sexually transmitted diseases (infections caused by Chlamydia trachomatis).
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: Pliva Hrvatska d.o.o.
-
The medicine is intended for the treatment of, among others, upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections (e.g., erysipelas, impetigo, adult acne), and certain sexually transmitted diseases.
Form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
Manufacturer: Teva Nederland B.V.
-
The medicine is intended for the treatment of, among others, upper respiratory tract infections (sore throat, tonsillitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections (erysipelas, impetigo, erythema migrans), and certain sexually transmitted diseases.
Form: capsules, hard
Active substance Dosage azithromycin 250 mg ATC: J01FA10
Manufacturer: Pliva Hrvatska d.o.o.
-
The medicine is used to treat infections caused by susceptible microorganisms, such as: bacterial sore throat, tonsillitis, sinusitis, acute otitis media, bronchitis, pneumonia, as well as skin and soft tissue infections (e.g., erysipelas, impetigo, erythema migrans).
Form: powder for preparation of oral suspension
Active substance Dosage azithromycin 50.094 mg/g ATC: J01FA10
Manufacturer: Pliva Croatia Ltd. (Pliva Croatia Ltd.) Teva Operations Poland Sp. z o.o.